Antrodia Cinnamomea Extract Effects on Lung Cancer Patients' Quality of Life During Chemotherapy
NCT07241182 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2026-01-08
Summary
This randomized trial will test whether Antrodia cinnamomea supplement improves quality of life in lung cancer patients receiving platinum-based chemotherapy.
Participants at Tri-Service General Hospital will be randomized to receive either Antrodia cinnamomea capsules or placebo for 3 months, with follow-up to 6 months (24 weeks). Primary outcomes include nausea/vomiting scores, sleep quality, quality of life, and cancer symptoms.
Conditions
- Lung Cancer (Diagnosis)
Interventions
- DIETARY_SUPPLEMENT
-
Antrodia cinnamomea supplement
Intervention Description: Oral capsules containing Antrodia cinnamomea fruiting body extract combined with turmeric and probiotics, administered once daily for 3 months during platinum-based chemotherapy treatment. Each capsule contains standardized amounts of Antrodia cinnamomea extract, curcumin (from turmeric), and probiotic strains.
- DIETARY_SUPPLEMENT
-
Turmeric-Probiotic Group
Capsules containing turmeric and probiotics (without Antrodia cinnamomea), same dosing schedule and appearance as experimental group.
Sponsors & Collaborators
-
Balay Biotechnology Corporation
collaborator UNKNOWN -
Tri-Service General Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-24
- Primary Completion
- 2027-03-31
- Completion
- 2027-09-30
Countries
- Taiwan
Study Locations
More Related Trials
-
A Study of AL8326 in Healthy Subjects
NCT07132957 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer
NCT03459729 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil
NCT01317550 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers
NCT03232138 ·Status: COMPLETED ·Phase: PHASE2
-
ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia
NCT00522197 ·Status: COMPLETED ·Phase: PHASE2
-
Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia
NCT00611650 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of PG2 on Fatigue-Related Symptom Clusters
NCT02740959 ·Status: COMPLETED ·Phase: NA
-
S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo
NCT00775645 ·Status: COMPLETED ·Phase: PHASE3
-
St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer
NCT00005805 ·Status: COMPLETED ·Phase: PHASE3
-
Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
NCT00004176 ·Status: COMPLETED ·Phase: PHASE2
-
Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy
NCT01636934 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma
NCT00689195 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer
NCT00033345 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer
NCT01746043 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer
NCT07152886 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Evaluation of Safety and Efficacy of Three Flavors of Supportan® Drink in Cancer Patients in Taiwan
NCT06902402 ·Status: COMPLETED ·Phase: NA
-
The Effects of Ginseng on Cancer-Related Fatigue
NCT01375114 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
To Evaluate the QoL Improvement of Oral Oligo Fucoidan in Subjects Receiving Platinum-based Chemotherapy With NSCLC
NCT03130829 ·Status: WITHDRAWN ·Phase: NA
-
Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma
NCT05019716 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Impact of Hospital Pharmacist on Drug Management in Patients With Bronchopulmonary Cancer
NCT06469957 ·Status: COMPLETED
-
Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma
NCT00002909 ·Status: COMPLETED ·Phase: PHASE1
-
High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer
NCT00003623 ·Status: COMPLETED ·Phase: PHASE3
-
American Ginseng in Treating Patients With Fatigue Caused by Cancer
NCT00719563 ·Status: COMPLETED ·Phase: PHASE3
-
Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer
NCT05232409 ·Status: RECRUITING ·Phase: PHASE1
-
Statin Therapy in Young Adult Survivors of Childhood Cancer
NCT01733953 ·Status: COMPLETED ·Phase: PHASE2